Tag Archives: Ivermectin

Ivermectin – Truth and Totalitarianism, by Justus R. Hope, MD

The drug companies are developing new, untested drugs for Covid while continuing to disparage Ivermectin. From Justus R. Hope, MD, at thedesertreview.com:

Calling out the lie

“Merck stock surged 10% Friday after it said its investigational pill cuts the risk of hospitalization and death in COVID-19 patients…The pill reduced the risk of hospitalization or death by about 50%,” Merck and its partner, Ridgeback Biotherapeutics, said in a statement Friday.


“This is a phenomenal result. This is a profound game-changer to have an oral pill that had this kind of effect, this magnitude of effect in patients who are at high risk who are already symptomatic,” former FDA Commissioner Scott Gottlieb said Friday on CNBC about results of the interim analysis.

“Meanwhile, shares of COVID vaccine makers Pfizer and Moderna fell 2.5% and 10%, respectively.”

This puts Dr. Scott Gottlieb between a rock and a hard place. On the one hand, as a member of Pfizer’s Board of Directors, he is paid handsomely to attend a few board meetings per year, yet on the other hand, he must not be too glowing in his praise of the antiviral, which might lead people away from the Pfizer vaccine. Moreover, it could affect sales just as it has already dropped the stock price.

In 2020, Gottlieb was paid $338,587 by Pfizer. In 2020, he also earned $525,850 as a director of Illumina. Due to his former FDA Chief status, Gottlieb is in high demand as one word of favor from him can send a stock price soaring.



He has served on multiple other boards, including Tempus Labs, National Resilience, and the Mount Sinai Health System. It must be a daunting task to walk the line by promoting one corporate interest while not offending any of the others.

Continue reading→

Slowly, Then All at Once, by James Howard Kunstler

We’ve reached the inflection point of collapse. From James Howard Kunstler at kunstler.com:

You can start to wonder what, if anything, will be left standing of the life we once called “modern” when Christmas 2021 rolls around. Shopping? Motoring? Working? Mingling? Eating? Sleeping? Waking…? Suddenly, everything is coming apart.

The supply lines are wobbling and many will go down. No stuff, no parts, before long, no food. Energy supplies are shaky everywhere. China’s electric grid is going dark from insufficient coal. Russia lacks the surplus NatGas to keep Western Europe warm. Global shortages drive up US oil and gas prices while people lose jobs and incomes over vaccine mandates — meaning families will freeze as the daylight dwindles. “Joe Biden’s” dark winter is coming on fast.

Ol’ White Joe might be going soon, too, before his vaunted dark winter even arrives. Guess what’s on his schedule this Monday morning.  Answer: an airplane ride from Wilmington to Washington, some remarks at 11:15 about the debt ceiling, and then… nothing. Calling “a lid” on the day. The “president’s” mental mojo has sunk so low that his handlers won’t allow him to gab freely with the Democratic Party’s congressional caucus. They hustled him out of the room on Capitol Hill last week after he attempted a pep-talk to that posse in their deranged effort to pass a $3.5-trillion “social safety net” package that is just a giveaway to ward-heelers in “blue” cities.

But then, who can imagine Kamala Harris in the Oval Office? Surely not Kamala herself, who has been cringing out-of-sight for weeks as the situation worsens. No more trips to Texas to pretend to care about the foreign invasion at the Mexican border that she was assigned to manage. No more anything for Ms. Harris, except hunkering down in the old naval observatory in a paralysis of anxiety and nausea. Do they dare even letting her pretend to head the executive branch? Or does she just resign in tandem with Ol’ White Joe, propelling Nancy Pelosi into the job? That will light up our dark winter, won’t it?

Continue reading→

India’s Ivermectin Blackout – Part V: The Secret Revealed, by Justus R. Hope, M.D.

If this article has its facts straight, India is a monumental positive test of the effectiveness of Ivermectin. From Justus R. Hope, M.D. at thedesertreview.com:

Ivermectin use in India

On May 7, 2021, during the peak of India’s Delta Surge, The World Health Organization reported, “Uttar Pradesh (is) going the last mile to stop COVID-19.”


The WHO noted, “Government teams are moving across 97,941 villages in 75 districts over five days in this activity which began May 5 in India’s most populous state with a population of 230 million.”

The activity involved an aggressive house-to-house test and treat program with medicine kits.

The WHO explained, “Each monitoring team has two members who visit homes in villages and remote hamlets to test everyone with symptoms of COVID-19 using Rapid Antigen Test kits. Those who test positive are quickly isolated and given a medicine kit with advice on disease management.”

The medicines comprising the kit were not identified as part of the Western media blackout at the time. As a result, the contents were as secret as the sauce at McDonald’s.

The WHO continued, “On the inaugural day, WHO field officers monitored over 2,000 government teams and visited at least 10,000 households.”

This news story was published on the WHO Official Website in India. The website details the WHO’s work against COVID-19 in India, including a discussion about their “Online course for Rapid Response Teams.”


Such teams are the very government teams discussed above assigned to conduct the house-to-house test and treat program in Uttar Pradesh. In discussing the role of the Rapid Response Team (RRT), the WHO site reports,

“RRTs are a key component of a larger emergency response strategy that is essential for an efficient and effective response…WHO has produced and published this course for RRTs working at the national, sub-national, district, and sub-district levels to strengthen the pandemic response with support from the National Center for Disease Control, Ministry of Health & Family Welfare, Government of India, and the U.S. Centers for Disease  Control and Prevention.”

The Rapid Response Teams derive support from the United States CDC under the umbrella of the WHO. This fact further validates the Uttar Pradesh test and treat program and solidifies this as a joint effort by the WHO and CDC.


Perhaps the most telling portion of the WHO article was the last sentence, “WHO will also support the Uttar Pradesh government on the compilation of the final reports.”


None have yet been published.

Continue reading→

The Coordinated Attack on Ivermectin Is a Crime Against Humanity, by Louie Gohmert

The official concerted attacks on Ivermectin and Hydroxychloroquine to withhold cheap and effective medications from people who either want to prevent Covid or who have it and want to cure themselves, especially when the alternatives are ineffective and dangerous vaccines, is indeed a crime against humanity. From Louie Gohmert at amgreatness.com:

Make no mistake, the evil, deadly, coordinated globalist attacks we are currently witnessing on ivermectin will go down in history as a vicious crime against humanity.

Just as we saw with hydroxychloroquine last summer, government alphabet agencies, the medical industrial complex, and their willing accomplices in the media have recently made it clear that there is yet another safe, effective treatment for COVID-19 they wish to torpedo. It’s the latest naughty word which will get you censored on social media and mocked and belittled by late-night “comedians”: ivermectin.

While ivermectin has been used by certain brave doctors around the world to treat COVID-19 for over a year now, it only recently became the target of a multi-pronged attack, with the U.S. government, the media, and Big Pharma all playing important roles in the deadly dystopian disinformation campaign against the drug. As more Americans became aware of ivermectin’s efficacy against COVID-19, like clockwork the government and its propaganda arm in the press jumped in to discredit it, referring to the drug snidely as a “horse dewormer.” 

We watched the FDA embarrass itself with its ridiculing tweet telling people “You are not a horse. You are not a cow. Seriously, y’all. Stop it,” while linking to an agency article on why people should not use ivermectin to treat or prevent the China Virus. We saw Rolling Stone magazine forced to admit that its recent story about Oklahoma hospitals being overwhelmed by patients who overdosed on ivermectin was completely false.

Omar Marques/SOPA Images via Getty Images

Pharmaceutical company Merck, which produces ivermectin, discredited its use for COVID by irresponsibly stating, “We do not believe that the data available support the safety and efficacy of ivermectin beyond the doses and populations indicated in the regulatory agency-approved prescribing information.” It is worth noting that Merck and Pfizer are developing their own oral antivirals that would directly compete with the cheap and effective ivermectin. These antivirals, unlike ivermectin, would be patented, creating the potential for pharmaceutical companies to rake in billions of dollars from their use.

Continue reading→

Pfizer Launches Final Study For COVID Drug That’s Suspiciously Similar To ‘Horse Paste’, by Tyler Durden

Imitation is the sincerest form of flattery. From Tyler Durden at zerohedge.com:

Another piece US anti-Ivermectin puzzle may have emerged. On Monday, Pfizer announced that it’s launching an accelerated Phase 2/3 trial for a COVID prophylactic pill designed to ward off COVID in those may have come in contact with the disease.

Coincidentally (or not), Pfizer’s drug shares at least one mechanism of action as Ivermectin – an anti-parasitic used in humans for decades, which functions as a protease inhibitor against Covid-19, which researchers speculate “could be the biophysical basis behind its antiviral efficiency.”

Lo and behold, Pfizer’s new drug – which some have jokingly dubbed “Pfizermectin,” is described by the pharmaceutical giant as a “potent protease inhibitor.”

As Zero Hedge readers might recognize, that’s exactly what ivermectin, the prophylactic used for a number of reasons in both humans and animals, does. And unlike Pfizer’s experimental drug, ivermectin already may have saved hundreds of thousands of lives from India to Brazil.

We aren’t the only ones to have put this together, as twitter users have commented on the similarities. The timing – which coincides with the whole “horse dewormer” smear campaign – just seems odd.

Continue reading→

MSN Showcases the Amazing Uttar Pradesh Turnaround–The Ivermectin-based Home Medicine Kits, by TrialSite Staff

It’s hard to write off the experiences of 230 million people as “anecdotal.” From the TrialSite Staff at trialsitenews.com:

Recently Indian press touted that Uttar Pradesh, India’s most populous state with about 230 million people was nearly COVID-19 free. An amazing accomplishment chronicled by TrialSite—a heroic public health story demonstrating how organized, proactive testing, early care, and quarantines contributed to overcoming an outright scary Delta variant-based surge from April to May of this year. The proactive use of Ivermectin, included in a home health care kit, showed to be instrumental in combating the incredibly virulent and transmissible strain of SARS-CoV-2. Public health workers made continuous visits to homes in villages and districts across the state, proactively testing and treating the condition immediately, including household contacts. Even the World Health Organization (WHO) praised the effort, yet omitted the use of Ivermectin—a scandal. Now Microsoft News (MSN) posted the story for the world to read, digest and hopefully understand.

MSN appears to be the first mainstream news source to recognize the amazing feat accomplished by the health agencies in India’s most populous state. The state experienced a massive spike in infections by April, but just two months later, the turnaround was well on its way, and what ensued should have been the story of the year.

The Outbreak

TrialSite provided in detail data associated with the Delta outbreak in India. The Delta variant of concern emerged from the State of Maharashtra and the Punjab regions by way of Lahore in Pakistan, locations where the AstraZeneca vaccine had been administered. Maps associated with the first outbreaks can be found here. Any correlation with vaccination, however, cannot be proven and may be coincidental.

Continue reading→

Horowitz: Heavily vaccinated state accounts for 65% of India’s COVID cases after rejecting ivermectin

This is just not supposed to be happening. Consequently, most people aren’t going to hear about it. From Daniel Horowitz at theblaze.com:

The Indian state of Kerala has 3% of India’s population, and 67% of its inhabitants have at least one vaccination. One would expect Kerala’s COVID cases to be so low as to be invisible in a chart of India’s very low overall cases. Yet this state of just 33 million people accounted for 65% of all of India’s cases on Thursday, and even more in recent weeks. It has essentially been the only state experiencing a surge in recent months. It also happens to be the Indian state that has rejected ivermectin.

I have written several columns on the miracle of Uttar Pradesh, India’s largest state, which has essentially eradicated COVID with the universal use of ivermectin. In general, most of India experienced very few COVID cases since the large spring wave because there is a great deal of immunity built up. However, Uttar Pradesh, despite its population of 240 million people, has been averaging fewer than 20 cases over the past few months for its seven-day rolling average.

This is India at large:

Now compare to Uttar Pradesh, which has a flat line rather than just a low churn.

Now let’s compare this to the state of Kerala, which has removed ivermectin and other proven therapeutics from its treatment protocol and has gone all in on the ineffective remdesivir.

Continue reading→

Ivermectin for COVID-19: real-time meta analysis of 63 studies

For those who insist on science, from ivmmeta.com h/t Bil:

Covid Analysis, Sep 14, 2021, Version 118discussion updates (V1 Nov 26, 2020)  [GMK response, Elgazzar

Meta analysis using the most serious outcome reported shows 69% [54‑79%] and 86% [75‑92%] improvement for early treatment and prophylaxis, with similar results after exclusion based sensitivity analysis and restriction to peer-reviewed studies or Randomized Controlled Trials.
Statistically significant improvements are seen for mortality, hospitalization, recovery, cases, and viral clearance. 29 studies show statistically significant improvements in isolation.
Studies Prophylaxis Early treatment Late treatment Patients Authors
All studies 63 86% [75‑92%] 69% [54‑79%] 40% [24‑52%] 26,422 623
Peer-reviewed 45 86% [74‑93%] 70% [52‑81%] 43% [21‑59%] 17,316 490
Randomized Controlled Trials 31 84% [25‑96%] 64% [48‑74%] 30% [2‑50%] 6,561 369
Percentage improvement with ivermectin treatment
There is evidence of a negative publication bias, and the probability that an ineffective treatment generated results as positive as the 63 studies is estimated to be 1 in 1 trillion.
While many treatments have some level of efficacy, they do not replace vaccines and other measures to avoid infection. Only 27% of ivermectin studies show zero events in the treatment arm.
Elimination of COVID-19 is a race against viral evolution. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. All practical, effective, and safe means should be used. Those denying the efficacy of treatments share responsibility for the increased risk of COVID-19 becoming endemic; and the increased mortality, morbidity, and collateral damage.
The evidence base is much larger and has much lower conflict of interest than typically used to approve drugs.
All data to reproduce this paper and sources are in the appendix. See [Bryant, Hariyanto, Kory, Lawrie, Nardelli] for other meta analyses with similar results confirming efficacy. et al.69%0.31 [0.20-0.47]Improvement, RR [CI]Bryant et al.62%0.38 [0.19-0.73]Lawrie et al.83%0.17 [0.08-0.35]Nardelli et al.79%0.21 [0.11-0.36]Hariyanto et al.69%0.31 [0.15-0.62]WHO (OR)81%0.19 [0.09-0.36]ivmmeta58%0.42 [0.30-0.59]Ivermectin meta analysis mortality resultsivmmeta.com Sep 14, 2021Lower Risk

Evidence base used for other COVID-19 approvals
Medication Studies Patients Improvement
Budesonide (UK) 1 1,779 17%
Remdesivir (USA) 1 1,063 31%
Casiri/imdevimab (USA) 1 799 66%
Ivermectin evidence 63 26,398 67% [59‑74%]

Continue reading→

The Immorality of Ignoring Ivermectin, by Parker Beauregard

How can a medical profession that is charged with doing all within its power to improve health and save lives ignore a Covid remedy that is safe and has been proven effective both anecdotally and in randomized and controlled trials? From Parker Beauregard at thebluestateconservative.com:

“While this court is sympathetic to the Plaintiff and understands the idea of wanting to do anything to help her loved one, public policy should not and does not support allowing a physician to try ‘any’ type of treatment on human beings.”

This was the stated decision by an Ohio judge on September 6th in response to experimental Covid treatments being administered to a hospital patient. Now, someone waking up from a coma might interpret this pronouncement as an end to vaccine mandates, and indeed most messaging around Covid vaccination in general. They would have good reason to suspect as much. After all, by the judge’s own logic, “public policy should not and does not support allowing a physician to try any type of treatment on human beings.” If an experimental, gene-altering vaccine that was rushed through production and approval does not qualify as “any type of treatment,” then what would?

Tragically, the judge’s did not relate to experimental and unproven vaccines; instead, it referred to the denial of a fifty-year-old generic drug with a proven safety record as a potential Covid therapeutic.

Judges in Ohio, unfortunately, are far from the only evil creatures wading into medical malpractice. Throughout the pandemic, mainstream media and political string-pullers have attempted to further discredit the phenomenal success of Ivermectin in places as diverse and far ranging as Buenos Aires, Mexico City, Peru, India, and elsewhere. Courageous doctors at America’s Frontline Doctors and Frontline Covid-19 Critical Care Alliance have developed successful treatment protocols,  who are at best are ignored, and at worst demonized, by the likes of corrupt individuals like Anthony Fauci and corrupt organizations like the CDC.

Continue reading→

Why all the fuss about Ivermectin? by Brian C. Joondeph

Like just about all drugs, Ivermectin can be dangerous and lethal if it is misused. Like many human drugs, it is also used on animals. So what? From Brian C. Joondeph at americanthinker.com:

First hydroxychloroquine, now ivermectin, is the hated deadly drug de jour, castigated by the medical establishment and regulatory authorities. Both drugs have been around for a long time as FDA-approved prescription medications. Yet now we are told they are as deadly as arsenic.

As a physician, I am certainly aware of ivermectin but don’t recall ever writing a prescription for it in my 30+ years’ medical career. Ivermectin is an anthelmintic, meaning it cures parasitic infections. In my world of ophthalmology, it is used on occasion for rare parasitic or worm infections in the eye.

Ivermectin was FDA approved in 1998 under the brand name Stromectol, produced by pharmaceutical giant Merck, approved for several parasitic infections. The product label described it as having a “unique mode of action,” which “leads to an increase in the permeability of the cell membrane to chloride ions.” This suggests that ivermectin acts as an ionophore, making cell membranes permeable to ions that enter the cell for therapeutic effect.

Ivermectin is one of several ionophores, others including hydroxychloroquine, quercetin, and resveratrol, the latter two available over the counter. These ionophores simply open a cellular door, allowing zinc to enter the cell, where it then interferes with viral replication, providing potential therapeutic benefit in viral and other infections.

Continue reading→